This inventor holds 1 USPTO granted patent. Top assignees: Keio University, Regimmune Corporation. Active years: 2021.
Company Filing History:
1 out of 360 
1 out of 3 Years Active: 2021
Title: Emi Kashiwabara: Innovator in Natural Killer T Cell Activation
Introduction
Emi Kashiwabara is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of immunology, particularly in the activation of natural killer T cells. His innovative work has led to the development of a unique compound that has potential applications in pharmaceutical compositions.
Latest Patents
Kashiwabara holds a patent for a compound or salt thereof that acts as a natural killer T cell activator. The patent addresses the need for a novel compound capable of activating these immune cells. The invention includes a natural killer T cell activating agent containing the compound and a pharmaceutical composition that incorporates it. The compound is represented by a specific formula, and it is designed to enhance the activation of natural killer T cells, which play a crucial role in the immune response.
Career Highlights
Throughout his career, Emi Kashiwabara has worked with prestigious institutions, including Keio University and Regimmune Corporation. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Kashiwabara has collaborated with notable colleagues such as Shinsuke Inuki and Natsumi Hirata. Their joint efforts have further advanced the research and development of natural killer T cell activators.
Conclusion
Emi Kashiwabara's innovative work in the field of natural killer T cell activation showcases his dedication to advancing immunological research. His contributions have the potential to lead to significant advancements in therapeutic applications.